Nivolumab & Ipilimumab + Zirdafulven

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Nivolumab & Ipilimumab + Zirdafulven
Treatment and conditionWhere it standsTrials
Nivolumab & Ipilimumab + Zirdafulven for neoplasm metastasisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1